Pulmonology Advisor (4/1, Stong) reports, “A notable proportion of Black, Hispanic, and White patients with interstitial lung disease (ILD) may not attain eligibility for antifibrotic therapy, clinical trials, and lung transplant referrals when race-based pulmonary function test (PFT) equations for determining eligibility are used, according to study findings.” Investigators came to this conclusion after evaluating “how the […]